These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Novel preparation and characterization of a trastuzumab-streptavidin conjugate for pre-targeted radionuclide therapy. Hainsworth JE; Harrison P; Mather SJ Nucl Med Commun; 2006 May; 27(5):461-71. PubMed ID: 16609358 [TBL] [Abstract][Full Text] [Related]
23. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin. Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488 [TBL] [Abstract][Full Text] [Related]
24. Trifunctional conjugation reagents. Reagents that contain a biotin and a radiometal chelation moiety for application to extracorporeal affinity adsorption of radiolabeled antibodies. Wilbur DS; Chyan MK; Hamlin DK; Kegley BB; Nilsson R; Sandberg BE; Brechbiel M Bioconjug Chem; 2002; 13(5):1079-92. PubMed ID: 12236790 [TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo evaluation of streptavidin immunoconjugates of the second generation TAG-72 monoclonal antibody CC49. Ngai WM; Reilly RM; Polihronis J; Shpitz B Nucl Med Biol; 1995 Jan; 22(1):77-86. PubMed ID: 7735174 [TBL] [Abstract][Full Text] [Related]
26. The localisation of radiolabelled murine monoclonal antibody 81C6 and its Fab fragment in human glioma xenografts in athymic mice. Colapinto EV; Lee YS; Humphrey PA; Zalutsky MR; Friedman HS; Bullard DE; Bigner DD Br J Neurosurg; 1988; 2(2):179-91. PubMed ID: 3267302 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies. Zalutsky MR; Moseley RP; Coakham HB; Coleman RE; Bigner DD Cancer Res; 1989 May; 49(10):2807-13. PubMed ID: 2469537 [TBL] [Abstract][Full Text] [Related]
28. Human/murine chimeric 81C6 F(ab')(2) fragment: preclinical evaluation of a potential construct for the targeted radiotherapy of malignant glioma. Boskovitz A; Akabani GH; Pegram CN; Bigner DD; Zalutsky MR Nucl Med Biol; 2004 Apr; 31(3):345-55. PubMed ID: 15028247 [TBL] [Abstract][Full Text] [Related]
29. Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphoma. Hamblett KJ; Press OW; Meyer DL; Hamlin DK; Axworthy D; Wilbur DS; Stayton PS Bioconjug Chem; 2005; 16(1):131-8. PubMed ID: 15656584 [TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants. Wilbur DS; Park SI; Chyan MK; Wan F; Hamlin DK; Shenoi J; Lin Y; Wilbur SM; Buchegger F; Pantelias A; Pagel JM; Press OW Bioconjug Chem; 2010 Jul; 21(7):1225-38. PubMed ID: 20597486 [TBL] [Abstract][Full Text] [Related]
32. Three-step tumor imaging with biotinylated monoclonal antibody, streptavidin and 111In-DTPA-biotin. Nakamoto Y; Saga T; Sakahara H; Yao Z; Zhang M; Sato N; Zhao S; Nakada H; Yamashina I; Konishi J Nucl Med Biol; 1998 Feb; 25(2):95-9. PubMed ID: 9468022 [TBL] [Abstract][Full Text] [Related]
33. Metal-Chelating Polymers (MCPs) with Zwitterionic Pendant Groups Complexed to Trastuzumab Exhibit Decreased Liver Accumulation Compared to Polyanionic MCP Immunoconjugates. Liu P; Boyle AJ; Lu Y; Adams J; Chi Y; Reilly RM; Winnik MA Biomacromolecules; 2015 Nov; 16(11):3613-23. PubMed ID: 26469142 [TBL] [Abstract][Full Text] [Related]
34. Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention. Wilbur DS; Chyan MK; Hamlin DK; Nguyen H; Vessella RL Bioconjug Chem; 2011 Jun; 22(6):1089-102. PubMed ID: 21513347 [TBL] [Abstract][Full Text] [Related]
35. A robust method for the preparation and purification of antibody/streptavidin conjugates. Hylarides MD; Mallett RW; Meyer DL Bioconjug Chem; 2001; 12(3):421-7. PubMed ID: 11353541 [TBL] [Abstract][Full Text] [Related]
36. Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study. Akabani G; Reardon DA; Coleman RE; Wong TZ; Metzler SD; Bowsher JE; Barboriak DP; Provenzale JM; Greer KL; DeLong D; Friedman HS; Friedman AH; Zhao XG; Pegram CN; McLendon RE; Bigner DD; Zalutsky MR J Nucl Med; 2005 Jun; 46(6):1042-51. PubMed ID: 15937318 [TBL] [Abstract][Full Text] [Related]
37. Tissue distribution and radiation dosimetry of astatine-211-labeled chimeric 81C6, an alpha-particle-emitting immunoconjugate. Zalutsky MR; Stabin MG; Larsen RH; Bigner DD Nucl Med Biol; 1997 Apr; 24(3):255-61. PubMed ID: 9228660 [TBL] [Abstract][Full Text] [Related]
38. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization. Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791 [TBL] [Abstract][Full Text] [Related]
39. Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft model. Wikstrand CJ; McLendon RE; Carrel S; Kemshead JT; Mach JP; Coakham HB; de Tribolet N; Bullard DE; Zalutsky MR; Bigner DD J Neuroimmunol; 1987 May; 15(1):37-56. PubMed ID: 3571486 [TBL] [Abstract][Full Text] [Related]
40. Immunotargeting of streptavidin to the pulmonary endothelium. Muzykantov VR; Atochina EN; Gavriljuk V; Danilov SM; Fisher AB J Nucl Med; 1994 Aug; 35(8):1358-65. PubMed ID: 8046494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]